Global Gene and Cell Therapies Targeting CNS Disorders Market – Competitive landscape
Key players operating in the global gene and cell therapies targeting CNS disorders market include Novartis, BrainStorm Cell Therapeutics, Corestem, Q Therapeutics, Helixmith, Rapa Therapeutics, Neuroplast, StemCyte, Ferrer Internacional, Neuralstem, Ferrer Internacional, Stemedica Cell Technologies, Libella Gene Therapeutics, Sangamo Therapeutics, Hoffmann-La Roche, Longeveron, Sio Gene Therapies, Eli Lilly and Company, NeuroGeneration, Brain Neurotherapy Bio (AskBio), and UniQure Biopharma.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients